Skip to main content

Advertisement

Log in

Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

The survival of patients with advanced gastric cancer after D2 dissection is still poor. Asian surgeons have proposed a more radical lymph node dissection, designated as D4 dissection, where paraaortic lymph nodes are removed in combination with D2 dissection. To evaluate the survival benefit of D4 dissection, a multi-institutional randomized trial of D2 vs D4 gastrectomy was conducted.

Methods

Patients enrolled in the study had potentially curable gastric adenocarcinoma at an advanced stage. Patients were randomized to undergo either D2 or D4 gastrectomy.

Results

Two hundred and ninety-three patients were registered and 269 patients were eligible; 135 patients were allocated to the D2 group and 134 to the D4 group. Five-year survival was 52.6% after D2 surgery and 55.0% after D4 gastrectomy. There was no significant difference in survival between the D2 and D4 groups (χ2 = 0.064; P = 0.801). Hospital deaths occurred in 1 patients (0.7%) in the D2 group and 5 in the D4 group D4 gastrectomy is a more risky surgery than D2 dissection. Seven patients (5.2%) in the D2 and 15 (11.2%) in the D4 group died of causes other than gastric cancer recurrence. Sixty-three patients (46.7%) in the D2 group and 52 (38.8%) in the D4 group had disease recurrence.

Conclusion

Prophylactic D4 dissection is not recommended for patients with potentially curable advanced gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kajitani T (1981) The general rules for the gastric cancer study in surgery and pathology: part 1-clinical classification. Jpn J Surg 11:127–139

    Article  PubMed  CAS  Google Scholar 

  2. Japanese Gastric Cancer Association (eds) (2004) Guidelines for the treatment of gastric cancer. Kanehara Shuppan, Tokyo

    Google Scholar 

  3. Bonenkamp JJ, Songu I, Herman J et al. (1995) Randomized comparison of mortality after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345:745–748

    Article  PubMed  CAS  Google Scholar 

  4. Cuschierib A, Fayers P, Fielding J, et al. (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MTC randomised controlled surgical trial. Lancet 347:995–999

    Article  Google Scholar 

  5. McCulloch P, Niita E, Kazi H, Gama-Rodrigues JJ (2005) Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg. 92:5–13

    Article  PubMed  CAS  Google Scholar 

  6. Shiu MH, Moore E, Sander M, et al. (1987) Influence of the extent of resection on survival after curative treatment of gastric cancer. Arch Surg 122:1347–1351

    PubMed  CAS  Google Scholar 

  7. Hartgrink HH, van de Verde CJH, Putter H, et al. (2004) Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol. 22:2069–2077

    Article  PubMed  CAS  Google Scholar 

  8. Roukos DH, Lorenz M, Encke A (1998) Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery 123:573–578

    Article  PubMed  CAS  Google Scholar 

  9. Hsu CP, Wu CC, Chen CY, et al. (1997) Clinical experience in radical lymphadenectomy for adenocarcinoma of the gastric cardia. J Thorac Cardiovasc Surg 114:544–551

    Article  PubMed  CAS  Google Scholar 

  10. Yonemura Y, Segawa M, Matsumoto H, et al. (1994) Surgical results of performing R4 gastrectomy for gastric cancer located in the upper third of the stomach. Jpn J Surg 24:488–493

    Article  CAS  Google Scholar 

  11. Yonemura Y, Wu CC, Fukushima N, et al. and the East Asia Surgical Oncology Group (2006) Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology 53:389–394

    PubMed  CAS  Google Scholar 

  12. Japanese Research Society for Gastric Cancer (1995) The general rules for the gastric cancer study in surgery and pathology. First English edition., Kanehara Shuppan, Tokyo

    Google Scholar 

  13. Sobin LH, Wittekind Ch (eds) (2002) UICC International Union Against Cancer TNM classification of malignant tumours. Sixth edition. John Wiley & Sons, pp 65–67

  14. Wu CC, Hsiung CA, Lo SS, et al. (2004) Randomized clinical trial of mortality after D1 and D3 surgery for gastric cancer. Br J Surg 91:283–287

    Article  PubMed  CAS  Google Scholar 

  15. Sano T, Sasako M, Yamamoto A, et al. (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group Study 9501. J Clin Oncol. 22:2767–2773

    Article  PubMed  Google Scholar 

  16. Desai AM, Pareek M, Nightingale G, et al. (2004) Improving outcomes in gastric cancer over 20 years. Gastric Cancer. 7:196–203

    Article  PubMed  Google Scholar 

  17. Di Leo A, Fedrazzani C, Bonfiglio M, et al. (2002) Superextended lymphadenectomy (D4) in the treatment of gastric cancer. Minerva Chir 57:641–647

    PubMed  Google Scholar 

  18. Kunisaki C, Shimada H, Yamaoka H, et al. (1994) Significance of para-aortic lymph node dissection in advanced gastric cancer. Hepatogastroenterology 46:2635–2642

    Google Scholar 

  19. Yonemura Y (1996) Extended radical gastrectomy: its indication and results. In: Yonemura Y (ed) Contemporary approaches toward cure of gastric cancer. Maeda Shoten, Kanazawa, pp 56–60

    Google Scholar 

  20. Yonemura Y (1996) Lymphatic systems of the stomach and the patterns of lymph node metastases. In: Yonemura Y (ed) Contemporary approaches toward cure of gastric cancer. Maeda Shoten, Kanazawa, pp 3–14

    Google Scholar 

  21. Natsugoe S, Nakashima S, Matsumoto M, et al. (1999) Paraaortic lymph node micrometastasis and tumor cell microinvolvement in advanced gastric carcinoma. Gastric Cancer 2:179–185

    Article  PubMed  Google Scholar 

  22. Shiu MH, Moore E, Sander M, et al. (1987) Influence of the extent of resection on survival after curative treatment of gastric cancer. Arch Surg 122:1347–1351

    PubMed  CAS  Google Scholar 

  23. Sasako M, Sano T, Yamamoto S, et al., Japan Clinical Oncology Group. Randomized phases III trial of standard D2 versus D2+paraaortic lymph node (PAN) dissection (D) for clinically M0 advanced gastric cancer: JCOG 9501. Abstract of 2006 ASCO Annual Meeting, www.asco.org

  24. Wu CW, Hsuing C, Lo SS, et al. (2006) Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol 7:309–315

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Yutaka Yonemura.

About this article

Cite this article

Yonemura, Y., Wu, CC., Fukushima, N. et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 13, 132–137 (2008). https://doi.org/10.1007/s10147-007-0727-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-007-0727-1

Key words

Navigation